Abstract
A peptide-polysaccharide, a peptide-rhamnomannan, was isolated from the pathogenic yeast form of the fungus Sporothrix schenckii. This substance, which may play a role in fungal virulence, was tested in an animal model of systemic disease, and depression of the immune response was observed in the animals between the 4th and 6th week of infection. Concomitantly, this compound showed mitogenic activity when challenged with normal lymphocytes and was also found to be involved in the inflammatory response. These results provide further information for the understanding of fungal implantation in tissues and of the pathogenicity of this systemic mycosis.
Similar content being viewed by others
References
Urabe H, Honbo S. Sporotrichosis. Intern J Dermatol 1986; 25: 255‐257.
Travassos LR, Lloyd KO. Sporothrix schenckii and related species of ceratocystis. Microbiol Rev 1980; 44: 683‐721.
Rippon JW. Sporotrichosis. In: Medical mycology ‐ the pathogenic fungi and the pathogenic actinomycetes. Chicago: W.B. Saunders Company, 1982: 227‐301.
Rafal ES, Rasmussen JE, Arbor A. An unusual presentations of fixed cutaneous sporotrichosis: A case report and review of the literature. J. Am Acad Dermatol 1991; 25: 928‐932.
Elgart ML. In: Boni E. Elwski, eds. Topics in clinical dermatology cutaneous fungal infections. New York, Tokyo: IgKu-Shoin, 1992: 124‐158.
Kaplan W, Ivens MS. Fluorescent antibody staining of Sporotrichum schenckii in cultures and clinical materials. J Invest Dermatol 1960; 35: 151‐159.
Roberts GD, Larsh HW. The serologic diagnosis of extracutaneous sporotrichosis. AJCP 1971; 56: 597‐600.
Meneghini CL, Angelini G, Boifazi E, Lospalluti M. Clinical and immunological aspects of sporotrichosis cutanea. Contact. Dermatitis 1978; 4: 33‐40.
Albornoz MB, Villanueva E, Torres EL. Application of immunoprecipitation techniques to the diagnosis of cutaneous and extracutaneous forms of sporotrichosis. Mycopathologia 1984; 85: 177‐183.
Bravo TC, Andrade A. Estudio de las cutirreacciones a la histoplasmina, coccidioidina, esporotricinas y lepromina. Salud Publica Mex 1968; 10: 173‐194.
Miranda RN. The importance of lote intradermal reactions (The Mitsuda phenomenon). Dermatol Intern 1969; 8: 79‐82.
Karlin JV, Nielsen HS. Serologic aspects of sporotrichosis. J Infect Dis 1970; 121: 316‐327.
Plouffe JF, Silva J, Fekety R, Reinhalter E, Browne R. Cell mediated immune responses in sporotrichosis. J Infect Dis 1979; 139: 152‐157.
Dominguez-Soto L, Hojyo-Tomoka MT. The intradermal sporotrichin test and the diagnosis of sporotrichosis. Intern J Dermatol 1983; 22: 520.
Carlos IZ. Contribuição ao estudo da infecção sistêmica pelo fungo Sporothrix schenckii em camundongos: avaliação do processo inflamatório e seu inter-relacionamento com a resposta imune celular (Thesis). Ribeirão Preto, SP, Brasil: Universidade de São Paulo, 1989. 104 p.
Lloyd KO, Bitton MA. Isolation and purification of a peptidorhamnomannan from yeast form of Sporothrix schenckii. Structural and immunochemical studies. J Immunol 1971; 7: 663‐671.
Radentz WH, Elewski BE. In: Boni E. Elewski, ed. Topics in clinical dermatology ‐ cutaneous fungal infections. New York, Tokyo: IgKu-Shoin, 1992: 184‐211.
Carloz IZ, Sgarbi DBG, Angluster J, Alviano CS, Silva CL. Detection of cellular immunity with the soluble antigen of the fungus Sporothrix schenckii in the systemic form of the disease. Mycopathologia 1992; 117: 139‐144.
Carloz IZ, Zini MMC, Sgarbi DBG, Angluster J, Alviano CS, Silva CL. Disturbances in the production of interleukin-1 tumor and necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994; 127: 189‐194.
Allen EM, Moore VL, Ebtevenb JO. Brain variation in BCG ‐ induced pulmonary inflammation in mice. J Immunol 1977; 119: 343‐347.
Cox RA. Immunology of the fungal diseases. Boca Raton, Florida: CRC Press, 1989.
Hiruma, M, Yamaji K, Shimizu T, Ohata H, Kukita a. Ultrastructural study of tissue reaction of mice against Sporothrix schenckii infection. Arch Dermatol Res 1988; 280: S94‐S100.
Hiruma M, Kawada A, Noda T, Yamazaki M, Ishibashi A. Tissue response in sporotrichosis: light and electron microscopy studies. Mycoses 1992; 35: 35‐41.
Gori S, Lupetti A, Moscato G, Parenti M, Lofaro A. Pulmonary sporotrichosis with hyphae in a human immunodeficiency virus ‐ infected patient. Acta Cytol 1974; 41: 519‐521.
Heller HM, Fuhrer J. Disseminated sporotrichosis in patients with AIDS: case report and review of the literature. AIDS 1991; 5: 1243‐1246.
Shaw JC, Levinson W, Montanaro A. Sporotrichosis in the acquired immunodeficiency syndrome. J. Amer Acad Dermatol 1989; 21: 1145‐1147.
Scott EN, Muchmore HG. Immunoblot analysis of antibody responses to Sporothrix schenckii. J Clin Microbiol 1989; 27: 300‐304.
Hamilton AJ, Harada T, Bartholomew MA, Figueroa JI, Fendon L, Hay RJ. Preparation of murine monoclonal antibodies against the yeast phase of the dimorphic fungus Sporothrix schenckii. Trans Royal Soc Trop Med Hug 1990; 84: 734‐737.
Benchimol M, Souza W, Travassos LR. Distribution of anionic groups at the cell surface of different Sporothrix schenckii cell types. Infect Immun 1979; 24: 912‐919.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Carlos, I.Z., Sgarbi, D.B.d.g. & Placeres, M.C.P. Host organism defense by a peptide-polysaccharide extracted from the fungus Sporothrix schenckii. Mycopathologia 144, 9–14 (1998). https://doi.org/10.1023/A:1006964516334
Issue Date:
DOI: https://doi.org/10.1023/A:1006964516334